DongKook Pharmaceutical Co., Ltd. (KOSDAQ: 086450)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,340
+20 (0.12%)
Sep 11, 2024, 11:13 AM KST

DongKook Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
718,442710,431729,658958,0731,285,488783,159
Upgrade
Market Cap Growth
30.46%-2.64%-23.84%-25.47%64.14%53.89%
Upgrade
Enterprise Value
786,861751,610743,265932,7781,201,020718,740
Upgrade
Last Close Price
16340.0016160.0016414.4121331.3428392.7117192.17
Upgrade
PE Ratio
13.4115.3213.8818.9422.7013.66
Upgrade
PS Ratio
0.940.971.101.612.301.62
Upgrade
PB Ratio
1.291.181.311.902.822.03
Upgrade
P/FCF Ratio
82.5393.28-104.16-150.8365.9217.66
Upgrade
P/OCF Ratio
18.4917.0017.8421.4621.7511.27
Upgrade
EV/Sales Ratio
1.031.031.121.572.151.49
Upgrade
EV/EBITDA Ratio
7.998.548.0211.5812.298.73
Upgrade
EV/EBIT Ratio
10.6411.2410.1114.7514.5410.46
Upgrade
EV/FCF Ratio
90.3998.69-106.10-146.8561.5916.21
Upgrade
Debt / Equity Ratio
0.120.130.120.190.150.16
Upgrade
Debt / EBITDA Ratio
0.770.870.721.220.700.73
Upgrade
Debt / FCF Ratio
8.7110.07-9.47-15.423.511.36
Upgrade
Asset Turnover
0.900.910.870.840.930.94
Upgrade
Inventory Turnover
2.332.482.532.693.173.08
Upgrade
Quick Ratio
1.271.341.491.402.152.47
Upgrade
Current Ratio
2.002.062.221.912.753.08
Upgrade
Return on Equity (ROE)
9.10%8.42%10.33%11.03%13.76%16.47%
Upgrade
Return on Assets (ROA)
5.46%5.20%6.05%5.59%8.55%8.38%
Upgrade
Return on Capital (ROIC)
6.86%6.41%7.51%7.02%10.64%10.32%
Upgrade
Earnings Yield
7.46%6.64%7.25%5.25%4.35%7.19%
Upgrade
FCF Yield
1.21%1.07%-0.96%-0.66%1.52%5.66%
Upgrade
Dividend Yield
1.10%1.11%----
Upgrade
Payout Ratio
15.26%17.07%15.22%15.99%12.79%8.26%
Upgrade
Buyback Yield / Dilution
-0.08%-0.02%-0.01%---0.94%
Upgrade
Total Shareholder Return
1.03%1.10%-0.01%---0.94%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.